ETHAMBUTOL Drug Patent Profile
✉ Email this page to a colleague
When do Ethambutol patents expire, and when can generic versions of Ethambutol launch?
Ethambutol is a drug marketed by Barr, Epic Pharma Llc, and Lupin. and is included in three NDAs.
The generic ingredient in ETHAMBUTOL is ethambutol hydrochloride. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the ethambutol hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ethambutol
A generic version of ETHAMBUTOL was approved as ethambutol hydrochloride by EPIC PHARMA LLC on November 30th, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ETHAMBUTOL?
- What are the global sales for ETHAMBUTOL?
- What is Average Wholesale Price for ETHAMBUTOL?
Summary for ETHAMBUTOL
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Drug Prices: | Drug price information for ETHAMBUTOL |
| DailyMed Link: | ETHAMBUTOL at DailyMed |


